New York City-based Alta Fundamental Advisers initiated a new position in Chemours Company during the third quarter. The fund reported 800,000 shares acquired with a net position change estimated at $12.67 million.

AutoZone (AZO) reported its Q1 results, showing a decline in EPS by 4.6% to $31.04, marking the sixth consecutive quarter of missing estimates. Revenue rose 8.2

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel.

Chemours (NYSE: CC - Get Free Report) and Kiwa Bio-Tech Products Group (OTCMKTS:KWBT - Get Free Report) are both basic materials companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability. Insider and Institutional Ownership 76.3% of

New York City-based Cooper Creek Partners bought nearly 4 million shares of The Chemours Company in the third quarter. The shares were worth about $63.1 million at the end of the quarter.

Chemours (NYSE: CC - Get Free Report) and Avient (NYSE: AVNT - Get Free Report) are both basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk. Dividends Chemours pays an annual dividend of $0.35 per

On Holding (ONON) saw a significant 19% increase in its stock after a strong Q3 earnings report and an upward revision of its guidance. The Swiss athletic footw

Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalization should help results bottom in 6–9 months.

CC posts a Q3 profit rebound with $60M in net income, driven by strong Thermal & Specialized Solutions amid mixed segment results.

The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Mizuho Securities USA LLC, Research Division Arun Viswanathan - RBC Capital Markets, Research Division Joshua Spector - UBS Investment Bank, Research Division Patrick Fischer - Goldman Sachs Group, Inc., Research Division Hassan Ahmed - Alembic Global Advisors Laurence Alexander - Jefferies LLC, Research Division Jeffrey Zekauskas - JPMorgan Chase & Co, Research Division Vincent Andrews - Morgan Stanley, Research Division Roger Spitz - BofA Securities, Research Division Aaron Rosenthal - JPMorgan Chase & Co, Research Division Presentation Operator Good morning. My name is Gigi, and I'll be your conference operator today.